Cita APA

Rossing, P., Filippatos, G. S., Agarwal, R. L., Anker, S. D., Pitt, B., Ruilope Urioste, L. M., . . . al., E. (2022). Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy.

Citación estilo Chicago

Rossing, Peter, et al. Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy. 2022.

Cita MLA

Rossing, Peter, et al. Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy. 2022.